• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl serves as advisor to Serendipity Partners in its acquisition of shares in Bluefish Pharmaceuticals

  • Home
  • Latest news
  • Cases and transactions
  • 2021
  • Lindahl serves as advisor to Serendipity Partners in its acquisition of shares in Bluefish Pharmaceuticals

Lindahl has advised the Norwegian fund Serendipity Partners on the acquisition of 25% of the shares in Bluefish Pharmaceuticals AB.

Bluefish Pharmaceuticals is a Swedish pharmaceutical company active in the development, manufacture and sale of generic drugs. Bluefish’s primary market for sales is the EU, but the company is expanding in areas outside Europe. Its product portfolio consists of approximately 70 products and continues to be developed.

Serendipity manages a fund that invests in companies focused on healthcare. Serendipity is an Oslo-based company that collaborates with founders and owners throughout the healthcare sector, with a particular focus on pharmaceuticals, diagnostics, healthcare providers and medical technology. Serendipity focuses on the Nordic region and Europe and has established a network of experienced leaders with experience from the healthcare sector that complements Bluefish Pharmaceutical’s geographical reach.

Lindahl’s team consisted of Mikael Smedeby, Erika Svensson, Disa Almqvist, Emira Peterson, Olov Kling and Amanda Sjöberg.

For further information about the transaction, see the parties’ press release.

Contact

  • Mikael Smedeby

    Uppsala

    mikael.smedeby@lindahl.se +46 708 161 875
  • Erika Svensson

    Uppsala

    erika.svensson@lindahl.se +46 704 215 839
  • Disa Almqvist

    Uppsala

    disa.almqvist@lindahl.se +46 708 621 453
  • Emira Peterson

    Uppsala

    emira.peterson@lindahl.se +46 762 297 419
  • Olov Kling

    Uppsala

    olov.kling@lindahl.se +46 702 101 379
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience